{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:20:20Z","timestamp":1790713220332,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"JSPS KAKENHI","award":["16K10371"],"award-info":[{"award-number":["16K10371"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00270-020-02673-5","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T13:05:28Z","timestamp":1603458328000},"page":"392-400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Arterial Embolization Using Microspheres for Hypervascular Liver Metastases Refractory to Standard Treatments: A Multicenter Prospective Clinical Trial"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4907-9111","authenticated-orcid":false,"given":"Masashi","family":"Shimohira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yozo","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Yasumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Masada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Yamakado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"2673_CR1","doi-asserted-by":"publisher","first-page":"55368","DOI":"10.18632\/oncotarget.10552","volume":"7","author":"J de Ridder","year":"2016","unstructured":"de Ridder J, de Wilt JH, Simmer F, Overbeek L, Lemmens V, Nagtegaal I. Incidence and origin of histologically confirmed liver metastases: an explorative case-study of 23,154 patients. Oncotarget. 2016;7:55368\u201376.","journal-title":"Oncotarget"},{"key":"2673_CR2","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/0002-9610(81)90057-X","volume":"141","author":"G Bengtsson","year":"1981","unstructured":"Bengtsson G, Carlsson G, Hafstr\u00f6m L, J\u00f6nsson PE. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg. 1981;141:586\u20139.","journal-title":"Am J Surg"},{"key":"2673_CR3","doi-asserted-by":"publisher","first-page":"53245","DOI":"10.18632\/oncotarget.10644","volume":"7","author":"Y Ren","year":"2016","unstructured":"Ren Y, Dai C, Zheng H, et al. Prognostic effect of liver metastasis in lung cancer patients with distant metastasis. Oncotarget. 2016;7:53245\u201353.","journal-title":"Oncotarget"},{"key":"2673_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s12094-019-02155-2","volume":"22","author":"X He","year":"2020","unstructured":"He X, Zhang Q, Feng Y, et al. Resection of liver metastases from breast cancer: a multicentre analysis. Clin Transl Oncol. 2020;22:512\u201321.","journal-title":"Clin Transl Oncol"},{"key":"2673_CR5","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1002\/cncr.22191","volume":"107","author":"MA Maluccio","year":"2006","unstructured":"Maluccio MA, Covey AM, Schubert J, et al. Treatment of metastatic sarcoma to the liver with bland embolization. Cancer. 2006;107:1617\u201323.","journal-title":"Cancer"},{"key":"2673_CR6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1159\/000336941","volume":"96","author":"F Maire","year":"2012","unstructured":"Maire F, Lombard-Bohas C, O\u2019Toole D, et al. Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: a prospective randomized study. Neuroendocrinology. 2012;96:294\u2013300.","journal-title":"Neuroendocrinology"},{"key":"2673_CR7","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/s11605-008-0640-6","volume":"12","author":"SC Pitt","year":"2008","unstructured":"Pitt SC, Knuth J, Keily JM, et al. Hepatic neuroendocrine metastases: chemo- or bland embolization? J Gastrointest Surg. 2008;12:1951\u201360.","journal-title":"J Gastrointest Surg"},{"key":"2673_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12020-013-0130-9","volume":"47","author":"F Fiore","year":"2014","unstructured":"Fiore F, Del Prete M, Franco R, et al. Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors. Endocrine. 2014;47:177\u201382.","journal-title":"Endocrine"},{"key":"2673_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00270-013-0691-2","volume":"37","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Nishiofuku H, Maeda S, et al. Repeated bland-TAE using small microspheres injected via an implantable port-catheter system for liver metastases: an initial experience. Cardiovasc Intervent Radiol. 2014;37:493\u20137.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2673_CR10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/107327480601300110","volume":"13","author":"JR Strosberg","year":"2006","unstructured":"Strosberg JR, Choi J, Cantor AB, Kvols LK. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors. Cancer Control. 2006;13:72\u20138.","journal-title":"Cancer Control"},{"key":"2673_CR11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jvir.2007.04.018","volume":"18","author":"AT Ruutiainen","year":"2007","unstructured":"Ruutiainen AT, Soulen MC, Tuite CM, et al. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. J Vasc Interv Radiol. 2007;18:847\u201355.","journal-title":"J Vasc Interv Radiol"},{"key":"2673_CR12","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/cncr.21389","volume":"104","author":"S Gupta","year":"2005","unstructured":"Gupta S, Johnson MM, Murthy R, et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer. 2005;104:1590\u2013602.","journal-title":"Cancer"},{"key":"2673_CR13","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1053\/j.tvir.2008.03.010","volume":"10","author":"A Laurent","year":"2007","unstructured":"Laurent A. Microspheres and nonspherical particles for embolization. Tech Vasc Interv Radiol. 2007;10:248\u201356. https:\/\/doi.org\/10.1053\/j.tvir.2008.03.010.","journal-title":"Tech Vasc Interv Radiol"},{"key":"2673_CR14","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s10147-012-0445-1","volume":"17","author":"K Osuga","year":"2012","unstructured":"Osuga K, Maeda N, Higashihara H, et al. Current status of embolic agents for liver tumor embolization. Int J Clin Oncol. 2012;17:306\u201315.","journal-title":"Int J Clin Oncol"},{"key":"2673_CR15","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s11604-016-0535-5","volume":"34","author":"K Osuga","year":"2016","unstructured":"Osuga K, Nakajima Y, Sone M, Arai Y, Nambu Y, Hori S. Transarterial embolization of hypervascular tumors using trisacryl gelatin microspheres (Embosphere): a prospective multicenter clinical trial in Japan. Jpn J Radiol. 2016;34:366\u201375.","journal-title":"Jpn J Radiol"},{"key":"2673_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.wneu.2017.09.147","volume":"109","author":"OO Akinduro","year":"2018","unstructured":"Akinduro OO, Mbabuike N, ReFaey K, et al. Microsphere embolization of hypervascular posterior fossa tumors. World Neurosurg. 2018;109:182\u20137.","journal-title":"World Neurosurg"},{"key":"2673_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/jfb9010014","volume":"9","author":"J Doucet","year":"2018","unstructured":"Doucet J, Kiri L, O\u2019Connell K, et al. Advances in degradable embolic microspheres: a state of the art review. J Funct Biomater. 2018;9:14.","journal-title":"J Funct Biomater"},{"key":"2673_CR18","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1007\/s00270-008-9369-6","volume":"31","author":"K Osuga","year":"2008","unstructured":"Osuga K, Hori S, Hiraishi K, et al. Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres. Cardiovasc Intervent Radiol. 2008;31:1108\u201316.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2673_CR19","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s11604-015-0486-2","volume":"33","author":"A Seki","year":"2015","unstructured":"Seki A, Hori S, Shimono C. Management of vascular lake phenomenon on angiography during chemoembolization with superabsorbent polymer microspheres. Jpn J Radiol. 2015;33:741\u20138.","journal-title":"Jpn J Radiol"},{"key":"2673_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30:52\u201360.","journal-title":"Semin Liver Dis"},{"key":"2673_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347.","journal-title":"Eur J Cancer"},{"key":"2673_CR22","unstructured":"US Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE). Version 4.0. Washington, DC: US Department of Health and Human Services, 2010."},{"key":"2673_CR23","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1245\/s10434-010-1505-2","volume":"18","author":"P Samaras","year":"2011","unstructured":"Samaras P, Breitenstein S, Haile SR, et al. Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases. Ann Surg Oncol. 2011;18:1924\u201331.","journal-title":"Ann Surg Oncol"},{"key":"2673_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1056\/NEJMoa033025","volume":"351","author":"D Cunningham","year":"2004","unstructured":"Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med. 2004;351:337\u201345.","journal-title":"N Engl J Med"},{"key":"2673_CR25","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1093\/annonc\/mdn370","volume":"19","author":"ML Rothenberg","year":"2008","unstructured":"Rothenberg ML, Cox JV, Butts C, et al. Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil\/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study. Ann Oncol. 2008;19:1720\u20136.","journal-title":"Ann Oncol"},{"key":"2673_CR26","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(12)61900-X","volume":"381","author":"A Grothey","year":"2013","unstructured":"Grothey A, Van Cutsem E, Sobrero A, et al. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet. 2013;381:303\u201312.","journal-title":"Lancet"},{"key":"2673_CR27","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S1470-2045(15)70156-7","volume":"16","author":"J Li","year":"2015","unstructured":"Li J, Qin S, Xu R, et al. Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2015;16:619\u201329.","journal-title":"Lancet Oncol"},{"key":"2673_CR28","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s12029-014-9663-2","volume":"45","author":"H Takaki","year":"2014","unstructured":"Takaki H, Litchman T, Covey A, et al. Hepatic artery embolization for liver metastasis of gastrointestinal stromal tumor following imatinib and sunitinib therapy. J Gastrointest Cancer. 2014;45:494\u20139.","journal-title":"J Gastrointest Cancer."},{"key":"2673_CR29","doi-asserted-by":"crossref","unstructured":"Brown DB, Fundakowski CE, Lisker-Melman M, et al. Comparison of MELD and Child\u2013Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol 2004; 15:1209\u201318.","DOI":"10.1097\/01.RVI.0000128123.04554.C1"},{"key":"2673_CR30","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1097\/01.RVI.0000182185.47500.7A","volume":"16","author":"CS Georgiades","year":"2005","unstructured":"Georgiades CS, Hong K, D\u2019Angelo M, Geschwind JF. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol. 2005;16:1653\u20139.","journal-title":"J Vasc Interv Radiol"},{"key":"2673_CR31","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/hep.1840190508","volume":"19","author":"L Mondazzi","year":"1994","unstructured":"Mondazzi L, Bottelli R, Brambilla G, et al. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology. 1994;19:1115\u201323.","journal-title":"Hepatology"},{"key":"2673_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/jjco\/hyf097","volume":"32","author":"M Ikeda","year":"2002","unstructured":"Ikeda M, Okada S, Yamamoto S, et al. Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization. Jpn J Clin Oncol. 2002;32:455\u201360.","journal-title":"Jpn J Clin Oncol"},{"key":"2673_CR33","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/hpb.12313","volume":"16","author":"JA White","year":"2014","unstructured":"White JA, Redden DT, Bryant MK, et al. Predictors of repeat transarterial chemoembolization in the treatment of hepatocellular carcinoma. HPB (Oxford). 2014;16:1095\u2013101.","journal-title":"HPB (Oxford)"},{"key":"2673_CR34","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s11604-012-0088-1","volume":"30","author":"K Yamakado","year":"2012","unstructured":"Yamakado K, Miyayama S, Hirota S, et al. Hepatic arterial embolization for unresectable hepatocellular carcinomas: do technical factors affect prognosis? Jpn J Radiol. 2012;30:560\u20136.","journal-title":"Jpn J Radiol"},{"key":"2673_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/01.RVI.0000052287.26939.b0","volume":"14","author":"JP Pelage","year":"2003","unstructured":"Pelage JP, Le Dref O, Beregi JP, et al. Limited uterine artery embolization with tris-acryl gelatin microspheres for uterine fibroids. J Vasc Interv Radiol. 2003;14:15\u201320.","journal-title":"J Vasc Interv Radiol"},{"key":"2673_CR36","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/sj.bjc.6605770","volume":"103","author":"M Cosimelli","year":"2010","unstructured":"Cosimelli M, Golfieri R, Cagol PP, et al. Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. Br J Cancer. 2010;103:324\u201331.","journal-title":"Br J Cancer"},{"key":"2673_CR37","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ijrobp.2005.12.051","volume":"65","author":"AS Kennedy","year":"2006","unstructured":"Kennedy AS, Coldwell D, Nutting C, et al. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys. 2006;65:412\u201325.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2673_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jvir.2011.09.028","volume":"23","author":"L Bester","year":"2012","unstructured":"Bester L, Meteling B, Pocock N, et al. Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients. J Vasc Interv Radiol. 2012;23:96\u2013105.","journal-title":"J Vasc Interv Radiol"},{"key":"2673_CR39","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00270-009-9658-8","volume":"32","author":"R Cianni","year":"2009","unstructured":"Cianni R, Urigo C, Notarianni E, et al. Selective internal radiation therapy with SIR-spheres for the treatment of unresectable colorectal hepatic metastases. Cardiovasc Intervent Radiol. 2009;32:1179\u201386.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2673_CR40","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.jvir.2008.05.013","volume":"19","author":"TF Jakobs","year":"2008","unstructured":"Jakobs TF, Hoffmann RT, Dehm K, et al. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases. J Vasc Interv Radiol. 2008;19:1187\u201395.","journal-title":"J Vasc Interv Radiol"},{"key":"2673_CR41","first-page":"571261","volume":"2011","author":"GW Nace","year":"2011","unstructured":"Nace GW, Steel JL, Amesur N, et al. Yttrium-90 radioembolization for colorectal cancer liver metastases: a single institution experience. Int J Surg Oncol. 2011;2011:571261.","journal-title":"Int J Surg Oncol."}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-020-02673-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-020-02673-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-020-02673-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T20:06:03Z","timestamp":1634933163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-020-02673-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["2673"],"URL":"https:\/\/doi.org\/10.1007\/s00270-020-02673-5","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,23]]},"assertion":[{"value":"17 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"We do not have any Conflict of Interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol, which was approved by the ethics committees of all institutions, was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all patients. This study was registered as Clinical Trials Registry no. UMIN000019848 ().","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Consent for publication was obtained by all authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}